Filing Flows › Fortress Biotech (FBIO) › Stock forecast & fair value
Fortress Biotech (FBIO) stock forecast and price target
Fortress Biotech (FBIO) trades at $1.85. One analyst's price target is $5.00 (+170%).
Fortress Biotech's latest quarter
Fortress Biotech, Q2 2026: revenue $18.7M (+14% year over year), operating margin -53.5%, net earnings $602K, operating cash flow −$59.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for FBIO stock?
One analyst's 12-month target is $5.00, +170% from $1.85. The average rating is none.
Does Fortress Biotech usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is FBIO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.